ARTICLE | Finance
Genzyme to VC
Termeer invests in $20M D round for diagnostics play NanoString
November 14, 2011 8:00 AM UTC
Henri Termeer is backing diagnostics play NanoString Technologies Inc., a company run by one of his former employees at Genzyme Corp.
NanoString President and CEO Brad Gray was VP of product and business development at the biotech's Genzyme Genetics diagnostic services division. Termeer, the former chairman, president and CEO of Genzyme, joined new investors General Electric Co. (NYSE:GE) and BioMed Ventures in NanoString's $20 million series D round...